We are live on ! Find out more
MBOT icon

Microbot Medical

37 hedge funds and large institutions have $12.6M invested in Microbot Medical in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $8.18M → $12.6M (+$4.39M)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 3637 (+1)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
1.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
10
Closed
4
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q2 2014 in Review

37 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2014, worth a combined $12.6M — up 54% from $8.18M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MBOT positions and 4 closed out — a net gain of 1 holder — while 9 added to existing stakes and 10 trimmed.

The largest buyer was Sphera Funds Management, opening a new position worth an estimated $713K. The largest seller was Compagnie Lombard Odier SCmA, cutting an estimated $443K.

  • 37 institutional investors held Microbot Medical (MBOT) as of Q2 2014, up from 36 in Q1 2014.
  • Funds reported $12.6M of Microbot Medical stock for Q2 2014, up 54% quarter-over-quarter.
  • 5 funds opened new Microbot Medical positions in Q2 2014 and 4 closed out, a net change of +1 holder.
  • The largest Microbot Medical buyer in Q2 2014 was Sphera Funds Management, an estimated $713K added.
  • The largest Microbot Medical seller in Q2 2014 was Compagnie Lombard Odier SCmA, an estimated $443K sold.

Based on aggregated 13F filings for Q2 2014.